Contact this trialFirst, we need to learn more about you.
Bruton's Tyrosine Kinase (BTK) Inhibitor
Long-term Remibrutinib for Chronic Hives
Recruiting1 awardPhase 3
Lincoln, Nebraska
This trial will investigate long-term effects of Remibrutinib on people with chronic hives. It will also provide access to those who participated in past trials.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.